Market Place
Sourcing Support
Wave Life Sciences to Present at Jefferies London Conference
15 Nov 2024 //
GLOBENEWSWIRE
Wave Life Sciences to Report Q3 2024 Results on Nov 12
04 Nov 2024 //
GLOBENEWSWIRE
Wave Life Sciences Highlights INHBE siRNA for Obesity
30 Oct 2024 //
GLOBENEWSWIRE
Takeda axes Huntington’s pact, freeing Wave to pursue partners
18 Oct 2024 //
FIERCE BIOTECH
Wave Life Announce Virtual Research Day on Wednesday, Oct 30, 2024
16 Oct 2024 //
GLOBENEWSWIRE
Wave Life Achieves 1st RNA Editing In Humans For Alpha-1 Antitrypsin
16 Oct 2024 //
GLOBENEWSWIRE
Wave Life Sciences Closes Upsized Public Offering of Shares
01 Oct 2024 //
GLOBENEWSWIRE
Wave Life Sciences To Present At Chardan Conference
30 Sep 2024 //
GLOBENEWSWIRE
Wave Life Sciences Prices $200 Million Public Offering
25 Sep 2024 //
GLOBENEWSWIRE
Wave Life Sciences Announces Positive Interim Data for WVE-N531
24 Sep 2024 //
GLOBENEWSWIRE
Wave Life Sciences Announces Public Offering of Ordinary Shares
24 Sep 2024 //
GLOBENEWSWIRE
Wave Life Sciences Gets FDA Rare Pediatric Status For DMD Treatment
12 Aug 2024 //
GLOBENEWSWIRE
Wave Life Sciences Reports Q2 2024 Results And Business Update
08 Aug 2024 //
GLOBENEWSWIRE
Wave Life Sciences Q2 2024 Results Call Set For August 8
01 Aug 2024 //
GLOBENEWSWIRE
Wave Life Sciences Reports Positive Results in SELECT-HD Trial
25 Jun 2024 //
GLOBENEWSWIRE
Wave Life Sciences Announces Upcoming Presentations On RNA
12 Jun 2024 //
GLOBENEWSWIRE
Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference
30 May 2024 //
GLOBENEWSWIRE
Wave Appoints Dr. Erik Ingelsson As Chief Scientific Officer
09 May 2024 //
GLOBENEWSWIRE
Wave Life Sciences Q1 2024 Financials And Business Update
09 May 2024 //
GLOBENEWSWIRE
Wave Life Sciences To Present At 2024 RBC Healthcare Conference
07 May 2024 //
GLOBENEWSWIRE
Wave Life Q1 2024 Results On May 9
02 May 2024 //
GLOBENEWSWIRE
Wave Life: CTA Approval For AATD Gene Therapy Trial RestorAATion-2
30 Apr 2024 //
GLOBENEWSWIRE
Wave Updates GSK RNAi Collaboration, RNA Editing Progress
23 Apr 2024 //
GLOBENEWSWIRE
Wave Life Sciences to Present at Upcoming Investor Conferences
27 Mar 2024 //
GLOBENEWSWIRE
Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results
06 Mar 2024 //
GLOBENEWSWIRE
Wave Life Q4 and Full Year 2023 Financial Results Scheduled for March 6, 2024
28 Feb 2024 //
GLOBENEWSWIRE
Wave Life Sciences Announces Upcoming Presentations at MDA Conference
27 Feb 2024 //
GLOBENEWSWIRE
Wave Life Sciences Highlights Recent Achievements and Upcoming 2024 Milestones
08 Jan 2024 //
GLOBENEWSWIRE
Wave Life Sciences to Present at 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 //
GLOBENEWSWIRE
Wave Life Announces Initiation of Dosing in Phase 2 FORWARD-53 Trial of WVE-N531
15 Dec 2023 //
GLOBENEWSWIRE
Wave makes $100M offering after dosing first subjects with RNA editing drug
07 Dec 2023 //
ENDPTS
Wave Life Announces Initiation of Dosing in RestorAATion Clinical Program
06 Dec 2023 //
GLOBENEWSWIRE
Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares
06 Dec 2023 //
GLOBENEWSWIRE
Wave Life Sciences to Present at 6áµ Annual Evercore ISI HealthCONx Conference
22 Nov 2023 //
GLOBENEWSWIRE
Wave Life Sciences Reports Third Quarter 2023 Financial Results
09 Nov 2023 //
GLOBENEWSWIRE
Wave Life Third Quarter 2023 Financial Results Scheduled for November 9, 2023
03 Nov 2023 //
GLOBENEWSWIRE
Wave Life Highlights Strategy for Building the Leading RNA Medicines Company
28 Sep 2023 //
GLOBENEWSWIRE
Wave Life Sciences to Present at the Chardan 7th Annual Conference
25 Sep 2023 //
GLOBENEWSWIRE
Wave Life Sciences to Present at H.C. Wainwright 25th Annual Global Conference
06 Sep 2023 //
GLOBENEWSWIRE
Wave readies clinical testing for first RNA editing therapy
06 Sep 2023 //
PRESS RELEASE
Wave Life Announces Submission of First Clinical Trial Application for WVE-006
05 Sep 2023 //
GLOBENEWSWIRE
Wave Life Sciences Reports Second Quarter 2023 Financial Results
03 Aug 2023 //
GLOBENEWSWIRE
Wave Life Sciences Q2 2023 Financial Results Scheduled for August 3, 2023
27 Jul 2023 //
GLOBENEWSWIRE
Wave Life Sciences Joins the Russell 2000® and Russell 3000® Indexes
26 Jun 2023 //
GLOBENEWSWIRE
Wave Life Announces Results from Phase 1b/2a FOCUS-C9 Study of WVE-004
23 May 2023 //
GLOBENEWSWIRE
Wave`s ALS-dementia drug crashes out after early-phase flop
23 May 2023 //
FIERCE BIOTECH
Wave Life Sciences to Highlight Leading RNA Editing Capability & Discovery
16 May 2023 //
GLOBENEWSWIRE
Wave Life Sciences Reports 1Q 2023 FYR and Provides Business Update
03 May 2023 //
GLOBENEWSWIRE
Wave Life Sciences 1Q 2023 FYR Scheduled for May 3, 2023
26 Apr 2023 //
GLOBENEWSWIRE
Wave Life Announces Nucleic Acids Research Publication Potential Best-in
20 Apr 2023 //
GLOBENEWSWIRE
Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results
22 Mar 2023 //
GLOBENEWSWIRE
Wave Life to Webcast Conference of Q4 and Full Year 2022 Financial Results
02 Mar 2023 //
GLOBENEWSWIRE
Wave Life Sciences to Present at the 2023 Virtual SVB Securities Conference
09 Feb 2023 //
GLOBENEWSWIRE
Wave Life Provides Positive Update on Proof-of-Concept Study for WVE-N531
19 Dec 2022 //
GLOBENEWSWIRE
GSK Strikes $3.3B Oligonucleotide Pact with Wave Life Sciences
14 Dec 2022 //
BIOSPACE
Wave Life Sciences to Present at the Stifel 2022 Healthcare Conference
09 Nov 2022 //
GLOBENEWSWIRE
Wave Life Sciences to Webcast Conference Call of 3Q FYR on November 10, 2022
03 Nov 2022 //
GLOBENEWSWIRE
Wave Life Sciences to Highlight Advancements from PRISM Platform
03 Oct 2022 //
GLOBENEWSWIRE
Wave Life Sciences Highlights Therapeutic Potential for WVE-006 f
28 Sep 2022 //
GLOBENEWSWIRE
Wave Life Sciences to Present at Chardan’s 6th Annual Genetic Medicines
27 Sep 2022 //
GLOBENEWSWIRE
